- Home
- OPFI vs PROF Comparison
OPFI vs PROF Comparison
Compare OPFI & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPFI
- PROF
- Stock Information
- Founded
- OPFI 2009
- PROF N/A
- Country
- OPFI United States
- PROF Canada
- Employees
- OPFI N/A
- PROF N/A
- Industry
- OPFI Finance: Consumer Services
- PROF Medical/Dental Instruments
- Sector
- OPFI Finance
- PROF Health Care
- Exchange
- OPFI Nasdaq
- PROF Nasdaq
- Market Cap
- OPFI 205.2M
- PROF 164.4M
- IPO Year
- OPFI N/A
- PROF N/A
- Fundamental
- Price
- OPFI $12.43
- PROF $4.27
- Analyst Decision
- OPFI Buy
- PROF Strong Buy
- Analyst Count
- OPFI 2
- PROF 2
- Target Price
- OPFI $11.75
- PROF $11.50
- AVG Volume (30 Days)
- OPFI 866.2K
- PROF 79.0K
- Earning Date
- OPFI 05-07-2025
- PROF 05-08-2025
- Dividend Yield
- OPFI 1.99%
- PROF N/A
- EPS Growth
- OPFI N/A
- PROF N/A
- EPS
- OPFI N/A
- PROF N/A
- Revenue
- OPFI $305,566,000.00
- PROF $11,862,000.00
- Revenue This Year
- OPFI $112.50
- PROF $71.17
- Revenue Next Year
- OPFI $7.84
- PROF $134.25
- P/E Ratio
- OPFI N/A
- PROF N/A
- Revenue Growth
- OPFI 31.46
- PROF 75.01
- 52 Week Low
- OPFI $2.82
- PROF $3.90
- 52 Week High
- OPFI $17.73
- PROF $11.42
- Technical
- Relative Strength Index (RSI)
- OPFI 76.20
- PROF 34.68
- Support Level
- OPFI $11.30
- PROF $4.62
- Resistance Level
- OPFI $12.30
- PROF $5.62
- Average True Range (ATR)
- OPFI 0.50
- PROF 0.42
- MACD
- OPFI 0.38
- PROF -0.01
- Stochastic Oscillator
- OPFI 94.31
- PROF 8.45
About OPFI OppFi Inc.
OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.